Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Cervical Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, Follicular 4 Lymphoma 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Accelerated Phase 2 Immunoblastic Lymphadenopathy 2 Congenital Abnormalities 2 Breast Neoplasms 2 Thrombocytopenia 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1

Interventions

Cisplatin 28 human papillomavirus vaccine, L1 type 16, 18 16 Brachytherapy 13 Bevacizumab 11 Paclitaxel 10 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 10 Platinum 9 1,2-diaminocyclohexaneplatinum II citrate 9 Topotecan 8 Radiation 8 Papillomavirus Vaccines 8 Radiotherapy, Intensity-Modulated 7 pembrolizumab 6 Cyclophosphamide 6 tisotumab vedotin 5 fludarabine phosphate 5 fludarabine 5 aldesleukin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Fluorodeoxyglucose F18 5 Carboplatin 5 atezolizumab 4 Vaccines, Synthetic 4 Taxes 4 Nivolumab 4 Colposcopy 4 Tobacco Use Cessation Devices 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡